Clinical trial Recruiting at 1 site Interventional Ages 19 and up

Detecting lower‑leg peripheral artery disease using segmental pulse arrival time

Official title: Pulse Arrival Time as an Alternative Biomarker to Detect Lower-Extremity Peripheral Artery Disease

Run by University of Nebraska · NCT07226193 · Data updated 2026-11-12

This trial will test whether measuring segmental pulse arrival time, and whether warming the skin or elevating the foot, can help detect lower‑leg peripheral artery disease in adults aged 19 and older.

Quick facts

Study typeInterventional
Ages19 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity of Nebraska
Academic / other
Locations1 site (Omaha, Nebraska)
StatusRecruiting
StartedFebruary 5, 2026
Main results expectedJanuary 1, 2028
Study endsJanuary 1, 2028
Registry record updatedSeptember 17, 2026
Trial IDNCT07226193 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 19 or older who can give informed consent and lie supine for testing, whether they have known PAD or not, and who do not have the listed exclusion conditions.

Probably not a fit

People with a current or prior aortic aneurysm, prior leg or aortic revascularization, walking impairments unrelated to limb ischemia, toe or foot gangrene or ulcers, or who are pregnant or breastfeeding may not be eligible or receive benefit from this test.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults 19 years and older with or without peripheral artery disease will complete a single laboratory visit with brief health and medication history, height/weight and body composition measured by bioelectrical impedance, and baseline rest in the supine position. Investigators will record segmental pulse arrival times and compare them to ankle‑brachial index and 6‑minute walk test results to see if PAT predicts PAD. The protocol includes experiments to test whether local toe/foot heating and foot elevation change PAT measurements and whether those changes improve PAD detection. The study will also analyze how age affects segmental PAT values.

Why it matters

Potential benefit: If successful, this approach could provide a simple, portable way to detect or screen for lower‑extremity PAD without complex imaging, enabling earlier diagnosis and monitoring.

How similar studies have gone: Pulse arrival time has been studied for arterial stiffness and central hemodynamics, but using segmental PAT specifically to detect lower‑extremity PAD is relatively novel with limited prior validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. be able to provide written informed consent
2. be 19 years of age or older
3. having or not having a diagnosis of peripheral artery disease

Exclusion Criteria:

1. having a current or pervious aortic aneurysm with or without previous intervention
2. having previous revascularization surgeries (open or endovascular) of the legs or aorta
3. having walking impairments independent of lower-limb ischemia (e.g., musculoskeletal injury)
4. having gangrene or ulcers of the toes/feet
5. being currently pregnant or breastfeeding

Where it's running

  • University of Nebraska at Omaha Health Science Collaborative
    Omaha, Nebraska, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.